Average Co-Inventor Count = 2.70
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-Myers Squibb Compnay (56 from 3,685 patents)
2. E. R. Squibb Sons, Inc. (2 from 1,624 patents)
58 patents:
1. 12421230 - Tricyclic heteroaryl compounds useful as IRAK4 inhibitors
2. 12391702 - Benzo[5,6][1,4]dioxino[2,3-b]pyridine compounds useful as IRAK4 inhibitors
3. 12304916 - Thienopyridinyl and thiazolopyridinyl compounds useful as IRAK4 inhibitors
4. 11623921 - Indole carboxamide compounds
5. 11479538 - Tetrazolone-substituted dihydropyridinone MGAT2 inhibitors
6. 11053197 - Carbazole derivatives
7. 10966967 - Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
8. 10829496 - Thienopyridines and benzothiophenes useful as IRAK4 inhibitors
9. 10695328 - Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
10. 10676434 - Carbazole derivatives
11. 10604504 - Indole carboxamide compounds
12. 10538505 - Tetrazolone-substituted dihydropyridinone MGAT2 inhibitors
13. 10369140 - Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
14. 10329274 - Indole carboxamide compounds
15. 10329273 - Tetrazolone-substituted dihydropyridinone MGAT2 inhibitors